Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 03, 16:00
Infinity Pharmaceuticals Shareholders Equity (Quarterly): -37.41M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -37.41M |
March 31, 2023 | -28.32M |
December 31, 2022 | -19.05M |
September 30, 2022 | -10.87M |
June 30, 2022 | -1.107M |
March 31, 2022 | 9.982M |
December 31, 2021 | 21.57M |
September 30, 2021 | 32.14M |
June 30, 2021 | 41.54M |
March 31, 2021 | 52.05M |
December 31, 2020 | -22.99M |
September 30, 2020 | -14.13M |
June 30, 2020 | -11.38M |
March 31, 2020 | -2.252M |
December 31, 2019 | 7.726M |
September 30, 2019 | 18.62M |
June 30, 2019 | 29.57M |
March 31, 2019 | 39.40M |
December 31, 2018 | 52.46M |
September 30, 2018 | 59.77M |
June 30, 2018 | 45.56M |
March 31, 2018 | 45.40M |
December 31, 2017 | 47.73M |
September 30, 2017 | 53.37M |
June 30, 2017 | 58.90M |
Date | Value |
---|---|
March 31, 2017 | 73.79M |
December 31, 2016 | 82.45M |
September 30, 2016 | 102.12M |
June 30, 2016 | 118.83M |
March 31, 2016 | 61.65M |
December 31, 2015 | 98.56M |
September 30, 2015 | 133.61M |
June 30, 2015 | 87.26M |
March 31, 2015 | 121.08M |
December 31, 2014 | 209.47M |
September 30, 2014 | 245.52M |
June 30, 2014 | 138.48M |
March 31, 2014 | 173.05M |
December 31, 2013 | 201.28M |
September 30, 2013 | 230.26M |
June 30, 2013 | 259.91M |
March 31, 2013 | 289.36M |
December 31, 2012 | 310.20M |
September 30, 2012 | 179.73M |
June 30, 2012 | -3.392M |
March 31, 2012 | 6.963M |
December 31, 2011 | 15.43M |
September 30, 2011 | 28.07M |
June 30, 2011 | 38.38M |
March 31, 2011 | 48.56M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-37.41M
Minimum
Jun 2023
52.05M
Maximum
Mar 2021
3.864M
Average
-1.107M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Athersys Inc | -36.40M |
Merck & Co Inc | 37.58B |
MEI Pharma Inc | 59.49M |
Humanigen Inc | -49.72M |
Bristol-Myers Squibb Co | 16.49B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 21.23M |
Total Liabilities (Quarterly) | 58.64M |
Current Ratio | 1.650 |